Leaders in monolith chromatography

Menu

History

Leaders in Monolith Separation Technology

history1BIA Separations is the only worldwide manufacturer of CIM Monolithic Columns. CIM technology is optimized to meet the research and production needs of the biotechnology industry.

BIA Separations was founded by a group of scientists and venture capital investors in 1998. Their common purpose was to become the world leader in innovative biochromatography by developing monolithic materials for preparative applications. Based on more than 15 years of experience, BIA Separations has developed a wide range of CIM Convective Interaction Media® monoliths that address the growing need for powerful and timesaving solutions in therapeutic biomolecule purification. Through both internal initiatives and external collaborations, this ISO certified company pursues the highest quality standards in its research, development, production, and customer service efforts. Additionally, BIA Separations uses its expertise in liquid chromatography to develop and validate analytical methods and design industrial purification processes. We are committed to providing our customers with the most reproducible and innovative products to meet their current and future separation needs.

Company Milestones

2012 BIA Separations and Showa Denko K.K. (SDK) have signed a strategic partnership agreement
2011 BIA Separations and JSR Corporation announced that they have entered a strategic partnership
2011 BIA Separations receives KAPPA-Health Award for being a model research intensive SME in EU Co-funded projects
2011 Analytical Contract Research Laboratory was approved by Agency for Medicinal Products and Medical Devices of the Republic Slovenia and is now the holder of laboratory quality control authorization according to EU GMP Volume 4, Chapter 7 – Contract Manufacture and Analysis.
2010 CIM® SO3 Monolithic Supports receive Drug Master File
2009 Pass second FDA audit for one of the projects
2008 Partnership with Agilent Technologies – develop and produce analytical monolithic columns
2006 First cGMP production of a vaccine (influenza) using CIM®
2006 CIM® QA Monolithic Supports receive Drug Master File Number (19695)
2004 5th Anniversary of BIA Separations
2003 ISO 9001:2000 Certification (Q-579)
2002 CIM® DEAE Monolithic Supports receive Drug Master File Number (15838) Analytical Lab Passes FDA Inspection
2001 BIA Separations and Boehringer Ingelheim announce cooperation in pDNA Manufacturing
1998 BIA Separations Founded